goserelin FDA approval date

The FDA approved goserelin (Zoladex) on 29 Dec 1989.

FDA approval date
29 Dec 1989

Drug identity checked against registry records

Also recorded as Zoladex

Included trials

TrialSponsorPhaseStatusPrimary completion
(Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast CancerNCT05607004ATOSPhase 2Active not recruiting2026-11Estimated

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
1989-12-29DaygoserelinFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA019726", "applicant_as_listed_by_fda": "TERSERA", "brand_names": ["ZOLADEX"], "active_ingredients": ["GOSERELIN ACETATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "19891229", "matched_on": "registry alias equals FDA brand name and drug name is its active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026